Want to see TSE:ASG full AI Analyst Report?
ASG Stock Chart & Stats
C$0.22
C$0.01(4.88%)
At close: 4:00 PM EDT
C$0.22
C$0.01(4.88%)
Day’s Range― - ―
52-Week RangeC$0.18 - C$0.33
Previous CloseN/A
Volume127.00
Average Volume (3M)30.19K
Market Cap
C$16.79M
Enterprise ValueC$12.84M
Total Cash (Recent Filing)C$778.55K
Total Debt (Recent Filing)C$2.26M
Price to Earnings (P/E)―
Beta0.31
Next Earnings
Aug 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding78,092,200
10 Day Avg. Volume38,837
30 Day Avg. Volume30,190
Financial Highlights & Ratios
PEG Ratio0.79
Price to Book (P/B)4.02
Price to Sales (P/S)0.83
P/FCF Ratio36.46
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improved Cash GenerationRecent TTM operating cash flow (~$1.21M) and free cash flow (~$0.76M) turned positive, demonstrating the business can self-fund operations and modest reinvestment. This reduces reliance on external financing and provides durable flexibility to support product development and working capital needs.
Strong Gross And Positive EBITDA MarginSustained TTM gross margin (~61%) and a positive EBITDA margin (~4.1%) indicate durable pricing power or cost advantage in core products. These margins create operating leverage potential as revenue stabilizes, supporting reinvestment and improving odds of converting to net profitability over several quarters.
Manageable LeverageLow 2025 debt-to-equity (~0.18) and positive equity provide financial flexibility, lowering interest burdens and enabling capital allocation for growth or R&D. Manageable leverage helps absorb revenue volatility and supports longer-term strategic moves without immediate refinancing pressure.
Bears Say
Material Revenue DeclineA material TTM revenue decline (-29.3%) signals weakening demand or market share pressure, which undermines the firm's ability to leverage fixed costs and to realize margin improvements. Sustained top-line contraction constrains reinvestment and makes achieving durable profitability harder.
Ongoing Net Losses And Negative ROEPersistent net losses (net margin ~-4.1%) and a TTM ROE near -18.9% indicate the company is not generating returns for shareholders. Continued losses erode capital, limit internal funding for growth initiatives, and may force dilutive financing or austerity measures to restore sustainable profitability.
Small Scale And Cash Flow VolatilityVery small scale (13 employees) combined with historically volatile cash flow restricts commercial reach, regulatory and clinical bandwidth, and the ability to scale operations. Limited scale increases execution risk during growth phases and can magnify the impact of revenue setbacks on financial health.
Aurora Spine News
ASG FAQ
What was Aurora Spine Corp’s price range in the past 12 months?
Aurora Spine Corp lowest stock price was C$0.18 and its highest was C$0.33 in the past 12 months.
What is Aurora Spine Corp’s market cap?
Aurora Spine Corp’s market cap is C$16.79M.
When is Aurora Spine Corp’s upcoming earnings report date?
Aurora Spine Corp’s upcoming earnings report date is Aug 26, 2026 which is in 12 days.
How were Aurora Spine Corp’s earnings last quarter?
Currently, no data Available
Is Aurora Spine Corp overvalued?
According to Wall Street analysts Aurora Spine Corp’s price is currently Overvalued.
Does Aurora Spine Corp pay dividends?
Aurora Spine Corp does not currently pay dividends.
What is Aurora Spine Corp’s EPS estimate?
Aurora Spine Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aurora Spine Corp have?
Aurora Spine Corp has 78,092,200 shares outstanding.
What happened to Aurora Spine Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Aurora Spine Corp?
Currently, no hedge funds are holding shares in TSE:ASG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Aurora Spine Corp
Established in 2013 and headquartered in Toronto, Canada, Aurora Spine Corporation, through its subsidiary Aurora Spine, Inc., specializes in the development and distribution of advanced, minimally invasive spinal fusion systems and devices within the Canadian market. The company offers a comprehensive portfolio of products designed to address various spinal conditions, particularly degenerative disc diseases. This includes interspinous process lumbar fusion devices such as the ZIP series (ZIP, ZIP ULTRA, ZIP LP, and ZIP-51). Aurora Spine also provides Ti-Coated polyether ether ketone (PEEK) interbody cages, which are crucial for maintaining space and stability between vertebrae while facilitating bone fusion. Its offerings extend to sterile-packed titanium plasma spray coated spinal fusion implants that promote bone growth. Key interbody products comprise EOS, VOX, Echo, Echo SD, and EchoXL for the lumbar region, and Discovery for cervical applications. The company also manufactures SOLO, an anterior lumbar interbody fusion (ALIF) 3D-printed stand-alone device featuring an integrated plate and spacer system for anatomical preservation and spinal support. For sacroiliac joint issues, Aurora Spine provides SiLo, a posterior fusion device. Furthermore, the DEXA-C cervical interbody system, a porous 3D-printed intervertebral body fusion device with customizable lattice density options, is available to match patient bone quality.
Technical Analysis
Perimeter Medical Imaging AI
―
―
Theralase Technologies
―
VentriPoint Diagnostics
―
―